Muscular Dystrophy Association (MDA), 2024

Mitochondrial Myopathies Mimicking Neuromuscular Diseases: A Case-Based Exploration

Tahseen Mozaffar

Response rates with zilucoplan among generalized myasthenia gravis patients in an interim analysis of RAISE-XT, a Phase 3 open-label extension study

Vu Tuan, M. Isabel Leite, Mantegazza Renato, et al.

Long-term safety of repeated cycles of rozanolixizumab treatment in patients with generalized myasthenia gravis

Vu Tuan, Grosskreutz Julian, Gayfieva Maryam, et al.

Repeated cycles of rozanolixizumab treatment in patients with muscle-specific kinase autoantibody-positive generalized myasthenia gravis

Habib A. Ali, Sacconi Sabrina, Pascuzzi M. Robert, et al.